These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Psychic energizers in the depressed patient. SENSEMAN LA R I Med J; 1961 Apr; 44():217-9. PubMed ID: 13750119 [No Abstract] [Full Text] [Related]
5. [Some results of the treatment of depressive states by a monoamine oxidase-inhibiting hydrazide, nialamide]. FOURNY L; SEGAL J; SEGAL A Toulouse Med; 1961 Feb; 62():137-41. PubMed ID: 13701049 [No Abstract] [Full Text] [Related]
6. A preliminary report on MAO inhibition and clincial effectiveness in the treatment of depressed patients with phenelzine. FELDSTEIN A; HOAGLAND H; RIVIERA MR; FREEMAN H J Neuropsychiatr; 1960; 2():12-4. PubMed ID: 13698729 [No Abstract] [Full Text] [Related]
7. [Clinical experience in the treatment of mental depression with and inhibitor of cerebral monoamine oxidase: beta-phenyl-isopropyl hydrazine]. CASTELLUCCIO R Sem Med; 1960 May; 116():867-80. PubMed ID: 13808292 [No Abstract] [Full Text] [Related]
8. [Anti-depressive chemotherapy]. QUETIN AM Gaz Med Fr; 1960 Sep; 67():1827-8. PubMed ID: 13738684 [No Abstract] [Full Text] [Related]
9. [Experiences in the treatment of depressive states with the new monoamine oxidase inhibitor 8-phenylethylhydrazine]. REMME KD Dtsch Med J; 1961 Apr; 12():228-32. PubMed ID: 13740775 [No Abstract] [Full Text] [Related]
10. [Therapy with phenelzine (Nardil) in certain depressive syndromes (clinical and biohumoral study)]. DE MAIO D; ORSI B; FAGGIOLI L Gazz Med Ital; 1961 Mar; 120():95-102. PubMed ID: 13720685 [No Abstract] [Full Text] [Related]
11. [Experiences in the treatment of depressive states with 1-seryl-2-isopropylhydrazine]. HEINRICH K Psychiatr Neurol (Basel); 1960 Jul; 140():119-25. PubMed ID: 13712966 [No Abstract] [Full Text] [Related]
12. Treatment of depressive states with marplan. OLTMAN JE; FRIEDMAN S Am J Psychiatry; 1960 Mar; 116():848-9. PubMed ID: 14428837 [No Abstract] [Full Text] [Related]
13. The variation in clinical response to Marplan with duration of illness. SCHOPBACH RR Am J Psychiatry; 1961 Feb; 117():746-7. PubMed ID: 13748502 [No Abstract] [Full Text] [Related]
14. Chemical treatment of depression. AYD FJ Ann N Y Acad Sci; 1959 Sep; 80():734-44. PubMed ID: 13795342 [No Abstract] [Full Text] [Related]
15. [Use of a monoamine oxidase inhibiting hydrazide, isocarboxazide for the treatment of mental depression]. RISER M; GAYRAL L; HURON R; TURNIN J; CARRIE J Toulouse Med; 1960 Oct; 61():707-13. PubMed ID: 13741834 [No Abstract] [Full Text] [Related]
16. Comparison of marplan and tofranil in the treatment of depressive states. OLTMAN JE; FRIEDMAN S Am J Psychiatry; 1961 Apr; 117():929-30. PubMed ID: 13730925 [No Abstract] [Full Text] [Related]
17. Experience with JB-516 and other psychochemicals. POMERANZE J Ann N Y Acad Sci; 1959 Sep; 80():835-42. PubMed ID: 14433949 [No Abstract] [Full Text] [Related]
18. The use of JB-516 in psychiatry. AGIN HV Ann N Y Acad Sci; 1959 Sep; 80():705-11. PubMed ID: 13792015 [No Abstract] [Full Text] [Related]
19. Clinical evaluation of psychostimulants. TOBIN JM; PLANTE MA; KUPSKI L Ann N Y Acad Sci; 1959 Sep; 80():760-71. PubMed ID: 13838589 [No Abstract] [Full Text] [Related]
20. Pharmacologic treatment of depression. GOLDMAN D Dis Nerv Syst; 1960 Mar; 21(3)Suppl():74-80. PubMed ID: 13850677 [No Abstract] [Full Text] [Related] [Next] [New Search]